Literature DB >> 22623680

A new mechanism for transmissible prion diseases.

Natallia Makarava1, Gabor G Kovacs, Regina Savtchenko, Irina Alexeeva, Valeriy G Ostapchenko, Herbert Budka, Robert G Rohwer, Ilia V Baskakov.   

Abstract

The transmissible agent of prion disease consists of prion protein (PrP) in β-sheet-rich state (PrP(Sc)) that can replicate its conformation according to a template-assisted mechanism. This mechanism postulates that the folding pattern of a newly recruited polypeptide accurately reproduces that of the PrP(Sc) template. Here, three conformationally distinct amyloid states were prepared in vitro using Syrian hamster recombinant PrP (rPrP) in the absence of cellular cofactors. Surprisingly, no signs of prion infection were found in Syrian hamsters inoculated with rPrP fibrils that resembled PrP(Sc), whereas an alternative amyloid state, with a folding pattern different from that of PrP(Sc), induced a pathogenic process that led to transmissible prion disease. An atypical proteinase K-resistant, transmissible PrP form that resembled the structure of the amyloid seeds was observed during a clinically silent stage before authentic PrP(Sc) emerged. The dynamics between the two forms suggest that atypical proteinase K-resistant PrP (PrPres) gave rise to PrP(Sc). While no PrP(Sc) was found in preparations of fibrils using protein misfolding cyclic amplification with beads (PMCAb), rPrP fibrils gave rise to atypical PrPres in modified PMCAb, suggesting that atypical PrPres was the first product of PrP(C) misfolding triggered by fibrils. The current work demonstrates that a new mechanism responsible for prion diseases different from the PrP(Sc)-templated or spontaneous conversion of PrP(C) into PrP(Sc) exists. This study provides compelling evidence that noninfectious amyloids with a structure different from that of PrP(Sc) could lead to transmissible prion disease. This work has numerous implications for understanding the etiology of prion and other neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623680      PMCID: PMC3368278          DOI: 10.1523/JNEUROSCI.6351-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

Review 1.  The transcellular spread of cytosolic amyloids, prions, and prionoids.

Authors:  Adriano Aguzzi; Lawrence Rajendran
Journal:  Neuron       Date:  2009-12-24       Impact factor: 17.173

2.  Neurodegeneration. Could they all be prion diseases?

Authors:  Greg Miller
Journal:  Science       Date:  2009-12-04       Impact factor: 47.728

Review 3.  Prion-like mechanisms in neurodegenerative diseases.

Authors:  Bess Frost; Marc I Diamond
Journal:  Nat Rev Neurosci       Date:  2009-12-23       Impact factor: 34.870

4.  In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

Authors:  Olga V Bocharova; Leonid Breydo; Alexander S Parfenov; Vadim V Salnikov; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2004-12-19       Impact factor: 5.469

5.  Strain-specified characteristics of mouse synthetic prions.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; Ilia V Baskakov; Fred E Cohen; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

6.  Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.

Authors:  Nathan R Deleault; James C Geoghegan; Koren Nishina; Richard Kascsak; R Anthony Williamson; Surachai Supattapone
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

Review 7.  Pathologic conformations of prion proteins.

Authors:  F E Cohen; S B Prusiner
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

8.  Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease.

Authors:  Olga V Bocharova; Leonid Breydo; Vadim V Salnikov; Andrew C Gill; Ilia V Baskakov
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

9.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Authors:  Natallia Makarava; Gabor G Kovacs; Olga Bocharova; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  Acta Neuropathol       Date:  2010-01-06       Impact factor: 17.088

10.  Protease-sensitive synthetic prions.

Authors:  David W Colby; Rachel Wain; Ilia V Baskakov; Giuseppe Legname; Christina G Palmer; Hoang-Oanh B Nguyen; Azucena Lemus; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more
  45 in total

1.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

2.  Synthetic Prions Provide Clues for Understanding Prion Diseases.

Authors:  Thibaut Imberdis; David A Harris
Journal:  Am J Pathol       Date:  2016-02-06       Impact factor: 4.307

3.  New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2016-02-09       Impact factor: 4.307

4.  Changes in prion replication environment cause prion strain mutation.

Authors:  Nuria Gonzalez-Montalban; Young Jin Lee; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  FASEB J       Date:  2013-05-31       Impact factor: 5.191

5.  Heterogeneous seeding of a prion structure by a generic amyloid form of the fungal prion-forming domain HET-s(218-289).

Authors:  William Wan; Wen Bian; Michele McDonald; Aleksandra Kijac; David E Wemmer; Gerald Stubbs
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

6.  Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.

Authors:  Gabor G Kovacs; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

7.  Mammalian prion amyloid formation in bacteria.

Authors:  Bruno Macedo; Yraima Cordeiro; Salvador Ventura
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

8.  Structural studies of truncated forms of the prion protein PrP.

Authors:  William Wan; Holger Wille; Jan Stöhr; Amy Kendall; Wen Bian; Michele McDonald; Sarah Tiggelaar; Joel C Watts; Stanley B Prusiner; Gerald Stubbs
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

9.  Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

10.  Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.